These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 15122328

  • 1. Overexpression of sprouty 2 inhibits HGF/SF-mediated cell growth, invasion, migration, and cytokinesis.
    Lee CC, Putnam AJ, Miranti CK, Gustafson M, Wang LM, Vande Woude GF, Gao CF.
    Oncogene; 2004 Jul 01; 23(30):5193-202. PubMed ID: 15122328
    [Abstract] [Full Text] [Related]

  • 2. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R.
    Cancer Res; 2005 Oct 15; 65(20):9355-62. PubMed ID: 16230398
    [Abstract] [Full Text] [Related]

  • 3. HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice.
    Weimar IS, Weijer K, van den Berk PC, Muller EJ, Miranda N, Bakker AQ, Heemskerk MH, Hekman A, de Gast GC, Gerritsen WR.
    Br J Cancer; 1999 Sep 15; 81(1):43-53. PubMed ID: 10487611
    [Abstract] [Full Text] [Related]

  • 4. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
    Ye M, Hu D, Tu L, Zhou X, Lu F, Wen B, Wu W, Lin Y, Zhou Z, Qu J.
    Invest Ophthalmol Vis Sci; 2008 Feb 15; 49(2):497-504. PubMed ID: 18234991
    [Abstract] [Full Text] [Related]

  • 5. Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis.
    Zhang YW, Wang LM, Jove R, Vande Woude GF.
    Oncogene; 2002 Jan 10; 21(2):217-26. PubMed ID: 11803465
    [Abstract] [Full Text] [Related]

  • 6. The HGF/SF-induced phosphorylation of paxillin, matrix adhesion, and invasion of prostate cancer cells were suppressed by NK4, an HGF/SF variant.
    Parr C, Davies G, Nakamura T, Matsumoto K, Mason MD, Jiang WG.
    Biochem Biophys Res Commun; 2001 Aug 03; 285(5):1330-7. PubMed ID: 11478803
    [Abstract] [Full Text] [Related]

  • 7. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM.
    Cancer Res; 2005 Sep 01; 65(17):7775-81. PubMed ID: 16140945
    [Abstract] [Full Text] [Related]

  • 8. Involvement of HGF/SF-Met signaling in prostate adenocarcinoma cells: evidence for alternative mechanisms leading to a metastatic phenotype in Pr-14c.
    MacDougall CA, Vargas M, Soares CR, Holzer RG, Ide AE, Jorcyk CL.
    Prostate; 2005 Jul 01; 64(2):139-48. PubMed ID: 15678502
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.
    Murai M, Shen X, Huang L, Carpenter WM, Lin CS, Silverman S, Regezi J, Kramer RH.
    Int J Oncol; 2004 Oct 01; 25(4):831-40. PubMed ID: 15375530
    [Abstract] [Full Text] [Related]

  • 10. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
    Tiran Z, Oren A, Hermesh C, Rotman G, Levine Z, Amitai H, Handelsman T, Beiman M, Chen A, Landesman-Milo D, Dassa L, Peres Y, Koifman C, Glezer S, Vidal-Finkelstein R, Bahat K, Pergam T, Israel C, Horev J, Tsarfaty I, Ayalon-Soffer M.
    Clin Cancer Res; 2008 Jul 15; 14(14):4612-21. PubMed ID: 18628476
    [Abstract] [Full Text] [Related]

  • 11. Knockdown of SMYD3 by RNA interference down-regulates c-Met expression and inhibits cells migration and invasion induced by HGF.
    Zou JN, Wang SZ, Yang JS, Luo XG, Xie JH, Xi T.
    Cancer Lett; 2009 Jul 18; 280(1):78-85. PubMed ID: 19321255
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. HGF/SF induces mesothelial cell migration and proliferation by autocrine and paracrine pathways.
    Warn R, Harvey P, Warn A, Foley-Comer A, Heldin P, Versnel M, Arakaki N, Daikuhara Y, Laurent GJ, Herrick SE, Mutsaers SE.
    Exp Cell Res; 2001 Jul 15; 267(2):258-66. PubMed ID: 11426944
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. HGF/SF-met signaling in the control of branching morphogenesis and invasion.
    Zhang YW, Vande Woude GF.
    J Cell Biochem; 2003 Feb 01; 88(2):408-17. PubMed ID: 12520544
    [Abstract] [Full Text] [Related]

  • 18. beta-Catenin and actin reorganization in HGF/SF response of ST14A cells.
    Soldati C, Biagioni S, Poiana G, Augusti-Tocco G.
    J Neurosci Res; 2008 Apr 01; 86(5):1044-52. PubMed ID: 17975841
    [Abstract] [Full Text] [Related]

  • 19. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ, Chen WK, Wang CJ, Lin WL, Tseng TH.
    Toxicol Appl Pharmacol; 2008 Jan 15; 226(2):178-91. PubMed ID: 17961621
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.